Skip to content

FORMA THERAPEUTICS HOLDINGS, INC.

CIK 0001538927

← back to feed
Revenue (TTM)
$0
Q2 Aug 2022
Net Income (TTM)
−$183.62M
−505.0% YoY Q2 Aug 2022
EPS Diluted (TTM)
−$1.98
−1.5% YoY Q2 Aug 2022
Gross Margin
—
Q2 Aug 2022
Operating Margin
—
Q2 Aug 2022
Net Margin
—
Q2 Aug 2022
Free Cash Flow (TTM)
−$153.97M
Q2 Aug 2022
Cash
$75.14M
Q2 Aug 2022
Total Debt
—
Q2 Aug 2022
Shares Outstanding
47.85M sh
Q2 Aug 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings